Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.30 |
| ▸ | F13A1 | P00488 | 3/20 | 0.30 |
| ▸ | PRKCA | P17252 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23111823 | 0.98 | TSHR (0.35) | TSHRLMNAMEN1GAAKMT2A | |
| SCHEMBL6767254 | 0.97 | TSHR (0.37) | TSHRMEN1GAAKMT2A | |
| SCHEMBL21333948 | 0.94 | PRKCA (0.33) | LMNAPRKCA | |
| SCHEMBL23355067 | 0.91 | LMNA (0.33) | LMNA | |
| SCHEMBL4858440 | 0.91 | LMNA (0.31) | LMNAPRKCA | |
| SCHEMBL22104501 | 0.85 | PRKCA (0.38) | MEN1KMT2APRKCA | |
| SCHEMBL208988 | 0.84 | TSHR (0.36) | TSHRLMNAMEN1GAAKMT2A | |
| SCHEMBL8379082 | 0.82 | FAAH (0.36) | TSHRMEN1GAAKMT2APTGER2 | |
| SCHEMBL29407564 | 0.81 | — | — | |
| SCHEMBL28854141 | 0.81 | ALDH1A1 (0.35) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4216929-A1 | SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND AN ACTIVE AGENT | Ocular Therapeutix, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-4203996-A1 | PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN | GlaxoSmithKline Biologicals SA (BE) | 2023-07-05 | — | — | EP | disclosed |
| EP-4009857-A1 | BIOERODIBLE CROSS-LINKED HYDROGEL IMPLANTS AND RELATED METHODS OF USE | DOSE Medical Corporation (US) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022043238-A1 | PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-03-03 | — | — | WO | disclosed |
| EP-3934696-A1 | CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES | GlaxoSmithKline Biologicals S.A. (BE) | 2022-01-12 | — | — | EP | disclosed |
| EP-3793622-A1 | EMBOLIC COMPOSITIONS AND METHODS | Incept, LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| WO-2021026214-A1 | BIOERODIBLE CROSS-LINKED HYDROGEL IMPLANTS AND RELATED METHODS OF USE | DOSE MEDICAL CORPORATION (US) | 2021-02-11 | — | — | WO | disclosed |
| WO-2020243602-A1 | BIOERODIBLE CROSS-LINKED HYDROGEL IMPLANTS AND RELATED METHODS OF USE | DOSE MEDICAL CORPORATION (US) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020182635-A1 | CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-09-17 | — | — | WO | disclosed |
| EP-3380077-A1 | SHAPE CHANGING DRUG DELIVERY DEVICES AND METHODS | Incept, LLC (US) | 2018-10-03 | — | — | EP | disclosed |
| EP-3294212-A1 | DRUG DELIVERY FROM HYDROGELS | Incept, LLC (US) | 2018-03-21 | — | — | EP | disclosed |
| EP-3229779-A1 | HYDROGEL DRUG DELIVERY IMPLANTS | Incept, LLC (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2017091749-A1 | SHAPE CHANGING DRUG DELIVERY DEVICES AND METHODS | INCEPT, LLC (US) | 2017-06-01 | — | — | WO | disclosed |
| WO-2016183296-A1 | DRUG DELIVERY FROM HYDROGELS | INCEPT, LLC (US) | 2016-11-17 | — | — | WO | disclosed |
| WO-2016094646-A1 | HYDROGEL DRUG DELIVERY IMPLANTS | INCEPT, LLC (US) | 2016-06-16 | — | — | WO | disclosed |
| EP-2787973-A1 | MEDICAL ORGANOGEL PROCESSES AND COMPOSITIONS | INCEPT LLC (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013086015-A1 | MEDICAL ORGANOGEL PROCESSES AND COMPOSITIONS | INCEPT, LLC (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-1979084-A2 | SYNTHESIS AND USE OF CROSS-LINKED HYDROPHILIC HOLLOW SPHERES FOR ENCAPSULATING HYDROPHILIC CARGO | APPLERA CORPORATION (US) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007102929-A2 | SYNTHESIS AND USE OF CROSS-LINKED HYDROPHILIC HOLLOW SPHERES FOR ENCAPSULATING HYDROPHILIC CARGO | APPLERA CORPORATION (US) | 2007-09-13 | — | — | WO | disclosed |